Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here.
Buongiorno! We’re now officially in this year’s home stretch. For me, that means I am flying home to Italy (with Tuna — please send any and all tips for long flights with spicy little dogs) at the end of this week. Meanwhile, don’t miss Allison DeAngelis’s fascinating profile on Reed Jobs and his investment in oncology.
Reed Jobs charts his own course in biotech
For Steve Jobs’ son, Reed, his father’s cancer wasn’t just cause for heartbreak and grief. It was also what led him down the path that culminated this past August with the founding of Yosemite, an investment firm focused exclusively on oncology research, with $200 million in financing and plans to raise $200 million more.
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect